VIROLOGICAL ASPECTS OF CFS / ME
1986
Medical consequences of persistent
viral infection. P Southern, MBA Oldstone.
The
Some problem areas in the interaction between viruses and the immune system. PC Doherty. Immunol. Cell Biol. 1986:65(Pt 4):279-286
1987
Coxsackie B Viruses and the Post-viral syndrome:
a prospective study in general practice. BD Calder, PJ Warnock et al. Journal
of the Royal
The Epstein-Barr Virus and Chronic Fatigue. IE Salit. Clinical Ecology 1987188:5:103-107
Chronic Enterovirus Infection in Patients with Postviral
Fatigue Syndrome. GE Yousef, EJ Bell et al. The Lancet
Chronic Fatigue Syndromes: relationship to chronic viral infections. AL Komaroff. Journal of Virological Methods 1988:21:3-10
1989
Viruses Can Cause Disease in the Absence of Morphological Evidence of Cell Injury: Implication for Uncovering New Diseases in the Future. MBA Oldstone. The Journal of Infectious Diseases 1989:159:3:384-389
1990
Persistence of Enteroviral RNA in Chronic Fatigue Syndrome is Associated
with the Abnormal Production of Equal Amounts of Positive and Negative Strands
of Enteroviral RNA. L
Myalgic encephalomyelitis - a persistent enteroviral infection? EG Dowsett, AM Ramsay et al. Postgrad Med J 1990:66:000-000 BU/1991
Reviews of Infectious Diseases. Vol. 13: Supplement 1: Jan-Feb 1991:S1-S140
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. JW Gow, WMH Behan et al. British Medical Journal 1991:302:692- 696
Mitochondrial abnormalities in the postviral fatigue syndrome. WMH Behan et al. Acta Neuropathol 1991:83:61- 65
1993
Enteroviruses and postviral fatigue syndrome.
1994
Changes in the 2-5A Synthetase/RNase L Antiviral Pathway in a Controlled Clinical Trial with Poly(I)-Poly(C12U) in Chronic Fatigue Syndrome. RJ Suhadolnik, NL Reichenbach et al. In vivo 1994:8:599 - 604
1997
Evidence for enteroviral persistence in humans. DN Galbraith et al. Journal of General Virology 1997:78:307-312
2000
Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. DV Ablashi, HB Eastman et al. Journal of Clinical Virology 2000:16:179 -191